Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Qualitek Labs IPO
Price Band
₹
Issue Size
₹19.64 Cr
Lot Size
1,200 shares
Min Investment
₹120,000
GMP
+₹60.0 (60.0%)
Issue Price
₹100.0
Subject to Sauda
₹54700
Paid only if allotted
Qualitek Labs IPO AI Summary
- Qualitek Labs IPO is listed on BSE SME in the Consulting Services sector.
- Subscription window: 18 Jan–23 Jan 2024, listing on 29 Jan 2024.
- Current GMP is +₹60.0 (60.0%) — unofficial and can change daily.
Qualitek Labs Limited is entering the market with an IPO priced at ₹100 per share. The company has shown growth in revenue and profit over the past few years, although recent figures indicate a decrease in income for the latest 9-month period. The proceeds from the IPO will be used for expanding laboratory facilities, repaying loans, and general corporate purposes. Investors should consider the associated risks and potential for listing gains.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Qualitek Labs IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 23 Jan 2024 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Qualitek Labs IPO Grey Market Premium (GMP) Today
GMP
+₹60.0
GMP %
+60.0%
Est. Listing
₹160.0
Updated: 25 Jul 2026 14:07
About the Company
Founded in 2018, Qualitek Labs Limited provides testing, inspection, homologation, certification, and consulting services. The company's laboratory services include: Automotive Testing Defence Product Testing Metals & Metallurgy Testing Mineral Testing Environment & Water Testing Food and Agriculture Testing Pharma & Healthcare They collaborate with industries such as automotive, defence, metals and metallurgy, environment and water, minerals, food and agriculture, and pharma and healthcare. The company has two testing laboratories in Pune and Bhubaneshwar. As of Jan 2024, the company has a total of 144 employees.
Company Financials (₹ Cr)
As of 2023-09-30
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 44.10 | 39.56 | 22.20 | 14.60 |
| Total Income | 12.51 | 19.35 | 12.02 | 6.37 |
| Profit After Tax | 2.01 | 2.97 | 1.14 | 0.46 |
| NET Worth | 11.87 | 9.87 | 1.90 | -0.23 |
| Reserves and Surplus | 6.47 | 4.46 | 1.44 | -0.24 |
| Total Borrowing | 25.00 | 23.45 | 17.29 | 11.22 |
Key Ratios
EPS
₹5.49
NAV
₹24.74
ROE
50.49%
ROCE
13.76%
RoNW
30.10%
P/B Value
4.04
P/E Ratio
18.21
Market Cap
₹73.72 Cr
PAT Margin
15.52%
Peer Comparison
| Company | RoNW | P/E (x) | EPS Basic | NAV | EPS Diluted |
|---|---|---|---|---|---|
| Choksi Laboratories Ltd. | 6.58% | 11.74 | 4.69 | — | — |
| Qualitek Labs Limited This IPO | 30.1% | 18.21 | 5.49 | 24.74 | 5.49 |
Promoters
Alok Kumar Agarwal, Antaryami Nayak, Kamal Grover and TIC Services Pvt.Ltd.
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding capital expenditure towards installation of plant and machinery for new & existing laboratories and for expansion of laboratories 6.22 2 Repayment of unsecured loan to Promoter 8.18 3 Funding of working capital requirements 2.50 4 General corporate purposes 1.41
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total Income was ₹6.37 Cr in the period ending 31 Mar 2021, rising to ₹12.02 Cr by 31 Mar 2022, then increasing to ₹19.35 Cr in the period ending 31 Mar 2023. However, in the latest period ending 30 Sep 2023, Total Income decreased to ₹12.51 Cr, though this is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit After Tax was ₹0.46 Cr in the period ending 31 Mar 2021, increasing to ₹1.14 Cr by 31 Mar 2022, and further rising to ₹2.97 Cr in the period ending 31 Mar 2023. The latest figure for Profit After Tax is ₹2.01 Cr for the period ending 30 Sep 2023, though this is a 9-month figure, not a full year, so isn't directly comparable.
Valuation
Qualitek Labs Limited's P/E ratio is 18.21 at the issue price, compared to its peer Choksi Laboratories Ltd., which has a P/E of 11.74. This indicates that Qualitek Labs is priced at roughly 1.55 times the trailing earnings of its peer.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected premium at which the shares might list compared to the issue price. A GMP of ₹60 suggests that the market anticipates the shares will list at ₹160, which is ₹60 above the issue price of ₹100.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy, considering factors such as the company's growth potential and market conditions.
Who May Want to Wait
Investors who are risk-averse or those who prefer stable, established companies may want to avoid investing in IPOs like this one, which can be subject to significant price fluctuations.
IPO Timeline, Explained
The IPO opens on January 18, 2024, and closes on January 23, 2024. Allotment of shares will be done on January 24, 2024, and the shares are expected to be listed on January 29, 2024.
Listing Gains — The Risk
While listing gains can be attractive, they are not guaranteed. The stock price on the listing day can be influenced by market conditions, investor sentiment, and overall demand for the shares. Investors should be prepared for the possibility of price fluctuations.
This evaluation is generated from Qualitek Labs's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Qualitek Labs IPO GMP today?
Qualitek Labs IPO GMP today is +₹60.0 (60.0%). GMP is an unofficial grey-market indicator and can change daily.
When does Qualitek Labs IPO open and close?
Qualitek Labs IPO opens on 18 January 2024 and closes on 23 January 2024.
When does Qualitek Labs IPO list on the stock exchange?
Qualitek Labs IPO listed on 29 January 2024 at ₹160.0.
What is the lot size for Qualitek Labs IPO?
The lot size for Qualitek Labs IPO is 1200 shares, requiring a minimum investment of ₹120,000.
What is the lot size for this IPO?
The lot size for Qualitek Labs Limited's IPO is 1200 shares.
What is the minimum investment required?
The minimum investment required is ₹120,000.
What is the issue price of the shares?
The issue price of the shares is ₹100.
When is the listing date for the shares?
The shares are expected to be listed on January 29, 2024.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected premium at which the shares might list compared to the issue price.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
18 Jan 2024
Close
23 Jan 2024
Allotment
24 Jan 2024
Listing
29 Jan 2024
Similar IPOs in Consulting Services
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Qualitek Labs?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.